- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/36 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from ActinomycesPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptomyces (G)
Patent holdings for IPC class C07K 14/36
Total number of patents in this class: 268
10-year publication summary
15
|
16
|
21
|
31
|
18
|
23
|
27
|
19
|
15
|
8
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19887 |
10 |
Pacific Biosciences of California, Inc. | 760 |
8 |
Savid Therapeutics Inc. | 17 |
8 |
University of Louisville Research Foundation, Inc. | 720 |
6 |
IBA Lifesciences GmbH | 28 |
6 |
Centre National de La Recherche Scientifique | 10418 |
5 |
Complecure, Inc. | 11 |
5 |
AgBiome, Inc. | 114 |
4 |
Fundamental Solutions Corporation | 29 |
4 |
IBA GmbH | 10 |
4 |
Institut Curie | 582 |
4 |
The MITRE Corporation | 444 |
4 |
The University of Tokyo | 4170 |
4 |
UTi Limited Partnership | 450 |
4 |
Sanofi | 4040 |
4 |
Evogene Ltd. | 148 |
3 |
Juno Therapeutics GmbH | 38 |
3 |
Juno Therapeutics, Inc. | 406 |
3 |
Marrone Bio Innovations, Inc. | 106 |
3 |
Medizinische Hochschule Hannover | 281 |
3 |
Other owners | 173 |